Lannett Co Inc (LCI):企業の財務・戦略的SWOT分析

◆英語タイトル:Lannett Co Inc (LCI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0061
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Lannett Co Inc (LCI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lannett Co Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, central nervous systems, gallstone, gastrointestinal, glaucoma, gout, migraine, muscle relaxant, obesity, pain management, respiratory, thyroid deficiency and urinary. Lannett also offers laboratory services, product formulation and development services, granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Philadelphia, Pennsylvania, the US.

Lannett Co Inc Key Recent Developments

Nov 06,2019: Lannett announces fiscal 2020 first-quarter financial results
Aug 29,2019: Lannett agrees to distribute Posaconazole tablets in US
Aug 27,2019: Lannett enters into advisory services agreement with strategic alliance partner
Aug 27,2019: Lannett announces fiscal 2019 fourth-quarter, full-year financial results; issues guidance for fiscal 2020
Aug 01,2019: Lannett appoints John Kozlowski CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Lannett Co Inc – Key Facts
Lannett Co Inc – Key Employees
Lannett Co Inc – Key Employee Biographies
Lannett Co Inc – Major Products and Services
Lannett Co Inc – History
Lannett Co Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Lannett Co Inc – Business Description
Lannett Co Inc – Corporate Strategy
Lannett Co Inc – SWOT Analysis
SWOT Analysis – Overview
Lannett Co Inc – Strengths
Lannett Co Inc – Weaknesses
Lannett Co Inc – Opportunities
Lannett Co Inc – Threats
Lannett Co Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Lannett Co Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 06, 2019: Lannett announces fiscal 2020 first-quarter financial results
Aug 29, 2019: Lannett agrees to distribute Posaconazole tablets in US
Aug 27, 2019: Lannett enters into advisory services agreement with strategic alliance partner
Aug 27, 2019: Lannett announces fiscal 2019 fourth-quarter, full-year financial results; issues guidance for fiscal 2020
Aug 01, 2019: Lannett appoints John Kozlowski CFO
May 24, 2019: Lannett announces CFO retirement
May 23, 2019: Lannett Company names Melissa V. Rewolinski, PhD, to Board Of Directors
May 13, 2019: US states file lawsuit against 20 drugmakers accused of price-fixing
May 06, 2019: Lannett announces fiscal 2019 third-quarter financial results
Mar 21, 2019: Lannett purchases $24 million of term loans in open market transactions
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Lannett Co Inc, Key Facts
Lannett Co Inc, Key Employees
Lannett Co Inc, Key Employee Biographies
Lannett Co Inc, Major Products and Services
Lannett Co Inc, History
Lannett Co Inc, Other Locations
Lannett Co Inc, Subsidiaries
Lannett Co Inc, Key Competitors
Lannett Co Inc, Ratios based on current share price
Lannett Co Inc, Annual Ratios
Lannett Co Inc, Annual Ratios (Cont...1)
Lannett Co Inc, Annual Ratios (Cont...2)
Lannett Co Inc, Interim Ratios
Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Lannett Co Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Lannett Co Inc, Performance Chart (2015 - 2019)
Lannett Co Inc, Ratio Charts
Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Lannett Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Lannett Co Inc (LCI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IDT Biologika GmbH-製薬・医療分野:企業M&A・提携分析
    Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a manufacturer of vaccines and bio-pharmaceuticals products. It offers services which include integrated development and manufacturing services in four major areas of animal health, vaccines, pharmaceuticals a …
  • New York Life Insurance Company:企業のM&A・事業提携・投資動向
    New York Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New York Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Red Electrica Corporacion SA (REE):企業の財務・戦略的SWOT分析
    Red Electrica Corporacion SA (REE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Pinetree Capital Ltd.:企業のM&A・事業提携・投資動向
    Pinetree Capital Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pinetree Capital Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Hertz Global Holdings Inc:企業の戦略・SWOT・財務情報
    Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Biowa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology inc …
  • BlackBerry Ltd:企業のM&A・事業提携・投資動向
    BlackBerry Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlackBerry Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • Guardant Health Inc (GH):企業の製品パイプライン分析2018
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Close Brothers Group Plc:企業の戦略・SWOT・財務分析
    Close Brothers Group Plc - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …
  • Ansaldo Energia SpA:電力:M&Aディール及び事業提携情報
    Summary Ansaldo Energia SpA (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipment and related services. It provides power plant equipment such as gas turbines, steam turbines, turbo generators, and hydro-generators used in fossil fue …
  • The J. R. Simplot Co:企業の戦略・SWOT・財務情報
    The J. R. Simplot Co - Strategy, SWOT and Corporate Finance Report Summary The J. R. Simplot Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Advantest Corporation:企業の戦略・SWOT・財務分析
    Advantest Corporation - Strategy, SWOT and Corporate Finance Report Summary Advantest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Isetan Mitsukoshi Holdings Ltd.:戦略・SWOT・企業財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • PT Berau Coal Energy Tbk:企業の戦略・SWOT・財務情報
    PT Berau Coal Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Berau Coal Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • National Rural Utilities Cooperative Finance Corporation:企業の戦略・SWOT・財務情報
    National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report Summary National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆